Maternal metabolic conditions may influence the risk of inflammatory diseases in offspring, yet the relationship between maternal type 2 diabetes mellitus (T2DM) and atopic dermatitis (AD) in children remains unclear.
Objective:
To evaluate the association between maternal T2DM and the development of AD in offspring.
Methods:
A retrospective cohort study of 314,224 mother–child pairs was conducted using electronic medical and birth records from Clalit Health Services in Israel (2010–2023). Maternal T2DM and child AD were identified by ICD-10 codes. Logistic regression was used to estimate adjusted odds ratios for AD, controlling for maternal age, socioeconomic status, gestational age, smoking, delivery type, ethnicity, and child sex.
Results:
Children born to mothers with T2DM had a lower crude prevalence of AD (23% vs 26%, P <0.001). Among mothers with T2DM, prior Glucagon-Like Peptide-1 (GLP-1) receptor agonist use was not associated with differences in offspring AD prevalence. After multivariable adjustment, maternal T2DM was not associated with AD (Adjusted Odds Ratio [aOR] = 0.95, 95% confidence interval: 0.87–1.03, P = 0.209). Higher socioeconomic status, parental smoking, male sex, and maternal allergic rhinitis were independent predictors of AD.
Conclusions:
Maternal T2DM was not found as a protective factor of AD in offspring. The observed protective trend may reflect confounding by sociodemographic or diagnostic factors. Prospective studies incorporating metabolic, immunological, and environmental data are warranted.
FasseehAN, ElezbawyB, KorraN, et al.Burden of atopic dermatitis in adults and adolescents: A systematic literature review. Dermatol Ther (Heidelb). 2022;12(12):2653–2668; doi: 10.1007/s13555-022-00819-6
4.
KimJ, KimBE, LeungDYM. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc. 2019;40(2):84–92; doi: 10.2500/aap.2019.40.4202
5.
CuiH, MuZ. Prenatal maternal risk factors contributing to atopic dermatitis: A systematic review and meta-analysis of cohort studies. Ann Dermatol. 2023;35(1):11–22; doi: 10.5021/ad.21.268
6.
ChenYJ, LinLZ, LiuZY, et al.Association between maternal gestational diabetes and allergic diseases in offspring: A birth cohort study. World J Pediatr. 2023;19(10):972–982; doi: 10.1007/s12519-023-00710-0
7.
RusconiF, GalassiC, ForastiereF, et al.Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children. Am J Respir Crit Care Med. 2007;175(1):16–21; doi: 10.1164/rccm.200512-1978OC
8.
YuanW, FonagerK, OlsenJ, et al.Prenatal factors and use of anti-asthma medications in early childhood: A population-based Danish birth cohort study. Eur J Epidemiol. 2003;18(8):763–768; doi: 10.1023/a:1025390420122
9.
YuanW, BassoO, SorensenHT, et al.Fetal growth and hospitalization with asthma during early childhood: A follow-up study in Denmark. Int J Epidemiol. 2002;31(6):1240–1245; doi: 10.1093/ije/31.6.1240
10.
SinDD, SpierS, SvensonLW, et al.The relationship between birth weight and childhood asthma: A population-based cohort study. Arch Pediatr Adolesc Med. 2004;158(1):60–64; doi: 10.1001/archpedi.158.1.60
11.
RasanenM, KaprioJ, LaitinenT, et al.Perinatal risk factors for asthma in Finnish adolescent twins. Thorax. 2000;55(1):25–31; doi: 10.1136/thorax.55.1.25
12.
RonaRJ, SmeetonNC, BustosP, et al.The early origins hypothesis with an emphasis on growth rate in the first year of life and asthma: A prospective study in Chile. Thorax. 2005;60(7):549–554; doi: 10.1136/thx.2004.032359
13.
LeadbitterP, PearceN, ChengS, et al.Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax. 1999;54(10):905–910; doi: 10.1136/thx.54.10.905
14.
XuB, PekkanenJ, LaitinenJ, et al.Body build from birth to adulthood and risk of asthma. Eur J Public Health. 2002;12(3):166–170; doi: 10.1093/eurpub/12.3.166
15.
BolteG, SchmidtM, MaziakW, et al.The relation of markers of fetal growth with asthma, allergies and serum immunoglobulin E levels in children at age 5-7 years. Clin Exp Allergy. 2004;34(3):381–388; doi: 10.1111/j.1365-2222.2004.01890.x
16.
RasanenM, KaprioJ, LaitinenT, et al.Perinatal risk factors for hay fever–a study among 2550 Finnish twin families. Twin Res. 2001;4(5):392–399; doi: 10.1375/1369052012579
17.
KerkhofM, KoopmanLP, van StrienRT, PIAMA Study Group. et al.Risk factors for atopic dermatitis in infants at high risk of allergy: The PIAMA study. Clin Exp Allergy. 2003;33(10):1336–1341; doi: 10.1046/j.1365-2222.2003.01751.x
18.
KumarR, OuyangF, StoryRE, et al.Gestational diabetes, atopic dermatitis, and allergen sensitization in early childhood. J Allergy Clin Immunol. 2009;124(5):1031–1038.e1-4; doi: 10.1016/j.jaci.2009.06.052
19.
HsuMC, LinCH, LinMC. Maternal gestational diabetes mellitus and risk of allergic diseases in offspring. Pediatr Neonatol. 2024;65(4):365–369; doi: 10.1016/j.pedneo.2023.06.012
20.
PanL, SongQ, XiongF, et al.Association between hypertensive disorders of pregnancy and gestational diabetes and risk of atopic dermatitis in childhood: A systematic review and meta-analysis. Taiwan J Obstet Gynecol. 2024;63(4):479–485; doi: 10.1016/j.tjog.2024.04.006
21.
BärensonA, TagomaA, VarendiH, HEDIMED investigator group. et al.Atopy and asthma in children born to mothers at risk of gestational diabetes mellitus: A follow-up study. BMC Pregnancy Childbirth.2024;24(1):610; doi: 10.1186/s12884-024-06819-y
22.
DiasS, PheifferC, AdamS. The maternal microbiome and gestational diabetes mellitus: Cause and effect. Microorganisms. 2023;11(9):2217; doi: 10.3390/microorganisms11092217
23.
HivertMF, BackmanH, BenhalimaK, et al.Pathophysiology from preconception, during pregnancy, and beyond. Lancet. 2024;404(10448):158–174; doi: 10.1016/S0140-6736(24)00827-4
24.
NolanCJ, DammP, PrentkiM. Type 2 diabetes across generations: From pathophysiology to prevention and management. Lancet (London, England). 2011;378(9786):169–181; doi: 10.1016/s0140-6736(11)60614-4
25.
GalazzoG, van BestN, BervoetsL, GI-MDH consortium. et al.Development of the microbiota and associations with birth mode, diet, and atopic disorders in a longitudinal analysis of stool samples, collected from infancy through early childhood. Gastroenterology. 2020;158(6):1584–1596.
26.
MousavianAH, Zare GariziF, GhoreshiB, et al.The association of infant and mother gut microbiomes with development of allergic diseases in children: A systematic review. J Asthma. 2024;61(10):1121–1135.
27.
OfenlochRF, SchuttelaarML, SvenssonÅ, et al.Socioeconomic status and the prevalence of skin and atopic diseases in five European countries. Acta Derm Venereol. 2019;99(3):309–314; doi: 10.2340/00015555-3082
28.
LiZ, YuM, WangP, et al.Association between maternal diabetes mellitus and allergic diseases in children - a systematic review and meta-analysis. Pediatr Allergy Immunol. 2021;32(5):880–891; doi: 10.1111/pai.13498
29.
AlharbiSH. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024;15:20420188231222367; doi: 10.1177/20420188231222367
30.
UrbanK, ChuS, GieseyRL, et al.The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017. JAAD Int. 2021;2:12–18; doi: 10.1016/j.jdin.2020.10.002
31.
SehgalVN, KhuranaA, MendirattaV, et al.Atopic dermatitis; etio-pathogenesis, an overview. Indian J Dermatol. 2015;60(4):327–331; doi: 10.4103/0019-5154.160474
